Chunchen Xiang
Overview
Explore the profile of Chunchen Xiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiang C, Ai W, Zhang Y
Front Neurol
. 2023 Jun;
14:1051382.
PMID: 37265466
Background: Previous studies have explored the application of non-invasive biomarkers of language dysfunction for the early detection of Alzheimer's disease (AD). However, language dysfunction over time may be quite heterogeneous...
2.
3.
Xiang C, Zhang Y
Neuropsychol Rev
. 2023 Mar;
34(2):402-416.
PMID: 36929474
Accumulating evidence has shown the effectiveness of cognitive interventions, which can be divided into cognitive training (CT), cognitive stimulation (CS), cognitive rehabilitation (CR), and combined interventions (i.e., cognitive interventions combined...
4.
Xiang C, Cong S, Tan X, Ma S, Liu Y, Wang H, et al.
NPJ Parkinsons Dis
. 2023 Mar;
9(1):39.
PMID: 36914663
No abstract available.
5.
Xiang C, Cong S, Tan X, Ma S, Liu Y, Wang H, et al.
NPJ Parkinsons Dis
. 2022 Nov;
8(1):165.
PMID: 36446820
Biomarkers play important roles in the diagnosis and differential diagnosis of Parkinson's disease (PD). Thus, we carried out a systematic review and meta-analysis evaluating the diagnostic utility of cerebrospinal fluid...
6.
Cong S, Xiang C, Zhang S, Zhang T, Wang H, Cong S
Neurosci Biobehav Rev
. 2022 Jun;
141:104749.
PMID: 35750224
Depression is one of the most important non-motor symptoms in Parkinson's disease (PD), but its prevalence and related clinical characteristics are unclear. To this end, we performed a systematic review...
7.
Xiang C, Cong S, Liang B, Cong S
J Transl Med
. 2020 Oct;
18(1):388.
PMID: 33054835
Background: Huntington's disease (HD) is a neurodegenerative disorder characterized by psychiatric symptoms, serious motor and cognitive deficits. Certain pathological changes can already be observed in pre-symptomatic HD (pre-HD) patients; however,...
8.
Cong S, Xiang C, Wang H, Cong S
J Neurol
. 2020 Mar;
268(8):2703-2712.
PMID: 32162061
Background: Multiple system atrophy (MSA) is an adult onset, fatal neurodegenerative disease. However, no reliable biomarker is currently available to guide clinical diagnosis and help to determine the prognosis. Thus,...
9.
Xiang C, Han S, Nao J, Cong S
Front Neurosci
. 2019 Nov;
13:1103.
PMID: 31680837
Multiple system atrophy (MSA) is an adult onset, fatal disease, characterized by an accumulation of alpha-synuclein (α-syn) in oligodendroglial cells. MicroRNAs (miRNAs) are small non-coding RNAs involved in post-translational regulation...
10.
Xiang C, Liu S, Fan Y, Wang X, Jia Y, Li L, et al.
Pharmacol Biochem Behav
. 2019 Apr;
180:74-82.
PMID: 30928299
The serotonergic system plays key regulatory roles in cognition and emotion. Several lines of evidence suggest that genetic variation is associated with aggressive and suicidal behaviors. Genetic studies have largely...